BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 5060671)

  • 1. The effect of portacaval anastomosis on oral carbohydrate tolerance and on plasma insulin levels.
    Holdsworth CD; Nye L; King E
    Gut; 1972 Jan; 13(1):58-63. PubMed ID: 5060671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma insulin disturbances in primary hyperparathyroidism.
    Kim H; Kalkhoff RK; Costrini NV; Cerletty JM; Jacobson M
    J Clin Invest; 1971 Dec; 50(12):2596-605. PubMed ID: 5129311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glucose tolerance and insulinemia in patients with hepatic cirrhosis and portal hypertension treated by portacaval anastomosis].
    Postiglione A; Casaretti B; Masciariello S; Riccardi G; Perrotti N; Lamenza F; Porcellini M; Mattioli PL
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):331-7. PubMed ID: 399734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of portacaval anastomosis on glucose tolerance in the dog: evidence of an interaction between the gut and the liver in oral glucose dosposal.
    Lickley HL; Chisholm DJ; Rabinovitch A; Wexler M; Dupre J
    Metabolism; 1975 Oct; 24(10):1157-68. PubMed ID: 1165730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose tolerance and insulin secretion in hyperthyroidism.
    Andersen OO; Friis T; Ottesen B
    Acta Endocrinol (Copenh); 1977 Mar; 84(3):576-87. PubMed ID: 320805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of glucose tolerance in 2600 histologically confirmed acute and chronic liver patients (author's transl)].
    Mütting D; Kaufmann M
    MMW Munch Med Wochenschr; 1975 Oct; 117(42):1689-94. PubMed ID: 810695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
    Serrano-Rios M; Ramos F; Rodriguez-Miñon JL; Vivanco F
    Diabetologia; 1970 Aug; 6(4):392-8. PubMed ID: 5456764
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose tolerance after portacaval shunt in liver cirrhosis.
    Pezzarossa A; Contini S; Bonora E; Marni A; Colotto G; Capocasale E; Butturini U
    Diabete Metab; 1986 Aug; 12(4):197-202. PubMed ID: 3533668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic consequences of portacaval shunting in the rat: effects on glucose tolerance and serum immunoreactive insulin response.
    Assal JP; Levrat R; Stauffacher W; Renold AE
    Metabolism; 1971 Sep; 20(9):850-8. PubMed ID: 5566160
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P; Ramahandridona G; Gerolami A
    Diabetes; 1974 Nov; 23(11):896-901. PubMed ID: 4430416
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis of pancreatic islet hyperplasia causing hypoglycemia in a patient with portacaval anastomosis.
    Brennan MD; Service FJ; Carpenter AM; Rubenstein AH; Edis AJ
    Am J Med; 1980 Jun; 68(6):941-8. PubMed ID: 6992572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbohydrate metabolism and pancreatic islet-cell function in thalassemia major.
    Costin G; Kogut MD; Hyman C; Ortega JA
    Diabetes; 1977 Mar; 26(3):230-40. PubMed ID: 320076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function.
    Geffner ME; Lippe BM; Kaplan SA; Itami RM; Gillard BK; Levin SR; Taylor IL
    Pediatr Res; 1984 Nov; 18(11):1107-11. PubMed ID: 6083538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
    Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
    J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous and exogenous insulin responses in patients with cystic fibrosis.
    Wilmshurst EG; Soeldner JS; Holsclaw DS; Kaufmann RL; Shwachman H; Aoki TT; Gleason RE
    Pediatrics; 1975 Jan; 55(1):75-82. PubMed ID: 1110865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose tolerance and insulin release in malnourished rats.
    Weinkove C; Weinkove EA; Pimstone BL
    Clin Sci Mol Med; 1976 Mar; 50(3):153-63. PubMed ID: 815069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.